Titagarh Rail Systems (NSE: TITAGARH) Q4 FY26 results: Why the order book looks strong but the FY27 execution test now matters more
Read More Pharma Industry News What makes Aptar Pharma’s latest nasal drug delivery bet a potential market disruptor? Aptar Pharma teams up with Dianosic to advance a bioresorbable nasal scaffold platform for chronic sinus and rhinitis care. Find out how this could reshape treatment. byPallavi MadhirajuSeptember 6, 2025